Seventure Partners is doubling down in the microbiome space with a new €200m fund Health for Life Capital II (HFL II). With 90% of limited partners from the first fund returning to back the new fund,
With the help of crowdfunding from everyday investors, start-up CNS Pharmaceuticals envisions an accelerated approval pathway with the US FDA for the anthracycline berubicin (RTA 744), which it says c
Almirall SA has appointed Peter Guenter CEO – effective Oct. 1. Guenter joins the company from Sanofi where he held various senior positions over the past 22 years, most recently as executiv
IN VITRO DIAGNOSTICS Mergers & Acquisitions Danaher Corp. Beckman Coulter Inc. IRIS International Inc. Medical and industrial products manufacturer Danaher Corp. is acquiring publicly traded IRI